Our partnerships extend throughout the drug discovery and development process
QurieGen’s single-cell response analysis technology can be applied at any of the three phases of the drug discovery and development process that all pharmaceutical companies need to go through to get their drugs to market.
Discovery Phase
- Finding new drug targets and combinations.
- Selecting leads based on favourable cell response patterns.
Pre-Clinical Phase
- Providing a high-resolution, quantitative MoA plan.
- Early identification of unwanted toxicity and non-responsive cells.
Clinical
Phase
- View of the heterogeneity of cell response.
- Detection of resistant cells subsets and other reasons for failure.